Rotavirus vaccine - Aventis Pasteur
Alternative Names: WC3Latest Information Update: 24 Oct 2021
At a glance
- Originator Nonindustrial source; Wistar Institute
- Developer sanofi pasteur; Wistar Institute
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Rotavirus infections
Most Recent Events
- 24 Dec 1999 Pasteur Mérieux Connaught is now a subsidiary of Aventis and its new name is Aventis Pasteur
- 22 Nov 1995 Phase-I clinical trials for Rotavirus infections in Israel (Unknown route)
- 22 Nov 1995 Phase-I clinical trials for Rotavirus infections in Mexico (Unknown route)